Metraipolis › archive › dc_4a028f7a2ed4

Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention-A… — Europe PMC PMID:42939546

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42939546
DOI
10.3390/cimb48101008
License (as archived)
solo-consultazione
Archived
2026-11-01T01:38:19.454Z
SHA-256 of the archived text
91dee88137792c84c33c58ab3e18f9210dd0c9e7480611858f4faa85b4392c39
Stable URL of this page
https://metraipolis.com/documento/dc_4a028f7a2ed4

How to cite

Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention-A… — Europe PMC PMID:42939546 — Europe PMC (en), https://europepmc.org/article/MED/42939546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a028f7a2ed4 (Metraipolis archive dc_4a028f7a2ed4, sha256 91dee88137792c84c33c58ab3e18f9210dd0c9e7480611858f4faa85b4392c39)
BibTeX
@misc{dc4a028f7a2ed4,
  title = {Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention-A… — Europe PMC PMID:42939546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42939546},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a028f7a2ed4; sha256 91dee88137792c84c33c58ab3e18f9210dd0c9e7480611858f4faa85b4392c39},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42939546. Agents can read the archived copy with the MCP tool read_document.